BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Tigerlily Foundation - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Tigerlily Foundation
X-ORIGINAL-URL:https://tigerlilyfoundation.org
X-WR-CALDESC:Events for Tigerlily Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250712T120000
DTEND;TZID=America/New_York:20250712T143000
DTSTAMP:20260516T235536
CREATED:20250618T210744Z
LAST-MODIFIED:20250710T175410Z
UID:10000820-1752321600-1752330600@tigerlilyfoundation.org
SUMMARY:Your Choice: Community Dialogues about Clinical Trials (DC)
DESCRIPTION:REGISTER TODAY!                                        \n                \n            \n\n\n\n        \n                \n        \n    \n    \n        \n        \n                        \n        \n                        \n                        \n                        \n                    \n\n        \n        Moderator:Daria L. Ross\, MPHPatient & Community Impact AdvocateTigerlily ANGEL Advocate \nPanelists:     \n\n        \n                \n                    \n\n        \n        Jessie Desir\, Ph.D.\, M.S. Ed.\, RN\, AMB-BC\, OCN Nurse EdVantage On-Call     \n\n        \n                    \n                    \n\n        \n        Megan O’NeilTLF ANGEL Advocate     \n\n        \n                    \n                    \n\n        \n        Frances MalinisTLF ANGEL Advocate     \n\n        \n                    \n                \n                \n                    \n\n        \n        Featured Resources to learn more about PIK3CA\, CDK4/6 Inhibitors\, breast cancer\, and a study opportunity near you:  \nhttps://rediscover2.com/    \n\n        \n                    \n                    \n\n        \n        Asking the Right Questions: Biomarkers\, PIK3CA & Personalized Breast Cancer Care     \n\n\n\n        \n                        \n                                                Click for Educational Content                                        \n                \n            \n\n        \n                    \n                \n                \n                    \n\n                \n            \n                                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                            \n        \n        \n        \n                    \n                    \n\n                \n            \n                                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                            \n        \n        \n        \n                    \n                    \n\n                \n            \n                                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                            \n        \n        \n        \n                    \n                \n                        \n        \n                        \n                        \n                        \n                    \n\n        \n                \n        \n    \n    \n        \n\n\n        \n        Learn more about Relay Therapeutics:  \nhttps://relaytx.com/    \n\n        \n                        \n        \n                        \n                        \n                        \n                    \n\n        \n        The information shared during this webinar is provided for educational and informational purposes only. It is not intended to replace professional medical advice\, diagnosis\, or treatment. Every person’s experience with breast cancer is unique. We encourage you to consult your physician or qualified healthcare provider with questions about your specific condition\, treatment options\, or medical decisions.\nTigerlily Foundation is committed to empowering patients with knowledge so they can engage in informed conversations with their healthcare teams.
URL:https://tigerlilyfoundation.org/event/your-choice-community-dialogues-about-clinical-trials-dc/
LOCATION:Smith Center for Healing and the Arts\, 1632 U Street\, Washington\, DC\, 20009\, United States
CATEGORIES:CHOICE
ATTACH;FMTTYPE=image/jpeg:https://tigerlilyfoundation.org/wp-content/uploads/2025/06/LinkedIn_Facebook.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20250712T120000
DTEND;TZID=America/Los_Angeles:20250712T143000
DTSTAMP:20260516T235537
CREATED:20250619T175141Z
LAST-MODIFIED:20250708T200426Z
UID:10000821-1752321600-1752330600@tigerlilyfoundation.org
SUMMARY:Your Choice: Community Dialogues about Clinical Trials (LA)
DESCRIPTION:REGISTER TODAY!                                        \n                \n            \n\n\n\n        \n                \n        \n    \n    \n        \n        \n                        \n        \n                        \n                        \n                        \n                    \n\n        \n        Moderator:Daria L. Ross\, MPHPatient & Community Impact AdvocateTigerlily ANGEL Advocate \nPanelists:     \n\n        \n                \n                    \n\n        \n        Jessie Desir\, Ph.D.\, M.S. Ed.\, RN\, AMB-BC\, OCN Nurse EdVantage On-Call     \n\n        \n                    \n                    \n\n        \n        Megan O’NeilTLF ANGEL Advocate     \n\n        \n                    \n                    \n\n        \n        Frances MalinisTLF ANGEL Advocate     \n\n        \n                    \n                \n                \n                    \n\n        \n        Featured Resources to learn more about PIK3CA\, CDK4/6 Inhibitors\, breast cancer\, and a study opportunity near you:  \nhttps://rediscover2.com/    \n\n        \n                    \n                    \n\n        \n        Asking the Right Questions: Biomarkers\, PIK3CA & Personalized Breast Cancer Care     \n\n\n\n        \n                        \n                                                Click for Educational Content                                        \n                \n            \n\n        \n                    \n                \n                \n                    \n\n                \n            \n                                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                            \n        \n        \n        \n                    \n                    \n\n                \n            \n                                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                            \n        \n        \n        \n                    \n                    \n\n                \n            \n                                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                            \n        \n        \n        \n                    \n                \n                        \n        \n                        \n                        \n                        \n                    \n\n        \n                \n        \n    \n    \n        \n\n\n        \n        Learn more about Relay Therapeutics:  \nhttps://relaytx.com/    \n\n        \n                        \n        \n                        \n                        \n                        \n                    \n\n        \n        The information shared during this webinar is provided for educational and informational purposes only. It is not intended to replace professional medical advice\, diagnosis\, or treatment. Every person’s experience with breast cancer is unique. We encourage you to consult your physician or qualified healthcare provider with questions about your specific condition\, treatment options\, or medical decisions.\nTigerlily Foundation is committed to empowering patients with knowledge so they can engage in informed conversations with their healthcare teams.
URL:https://tigerlilyfoundation.org/event/your-choice-community-dialogues-about-clinical-trials-la/
LOCATION:Cancer Support Community Los Angeles\, 1990 S. Bundy Drive\, Suite 100\, Los Angeles\, CA\, 90025\, United States
CATEGORIES:CHOICE
ATTACH;FMTTYPE=image/jpeg:https://tigerlilyfoundation.org/wp-content/uploads/2025/06/1200x630.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250731T173000
DTEND;TZID=America/New_York:20250731T193000
DTSTAMP:20260516T235537
CREATED:20250702T195919Z
LAST-MODIFIED:20250722T205120Z
UID:10000822-1753983000-1753990200@tigerlilyfoundation.org
SUMMARY:Your Choice: Community Dialogues about Clinical Trials (DC)
DESCRIPTION:REGISTER TODAY!                                        \n                \n            \n\n\n\n        \n                \n        \n    \n    \n        \n        \n                        \n        \n                        \n                        \n                        \n                    \n\n        \n        Moderator:Daria L. Ross\, MPHPatient & Community Impact AdvocateTigerlily ANGEL Advocate \nPanelists:     \n\n        \n                \n                    \n\n        \n        Jessie Desir\, Ph.D.\, M.S. Ed.\, RN\, AMB-BC\, OCN Nurse EdVantage On-Call     \n\n        \n                    \n                    \n\n        \n        Megan O’NeilTLF ANGEL Advocate     \n\n        \n                    \n                    \n\n        \n        Frances MalinisTLF ANGEL Advocate     \n\n        \n                    \n                \n                \n                    \n\n        \n        Featured Resources to learn more about PIK3CA\, CDK4/6 Inhibitors\, breast cancer\, and a study opportunity near you:  \nhttps://rediscover2.com/    \n\n        \n                    \n                    \n\n        \n        Asking the Right Questions: Biomarkers\, PIK3CA & Personalized Breast Cancer Care     \n\n\n\n        \n                        \n                                                Click for Educational Content                                        \n                \n            \n\n        \n                    \n                \n                \n                    \n\n                \n            \n                                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                            \n        \n        \n        \n                    \n                    \n\n                \n            \n                                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                            \n        \n        \n        \n                    \n                    \n\n                \n            \n                                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                                    \n                        \n                            \n                                                        \n                                                    \n                            \n        \n        \n        \n                    \n                \n                        \n        \n                        \n                        \n                        \n                    \n\n        \n                \n        \n    \n    \n        \n\n\n        \n        Learn more about Relay Therapeutics:  \nhttps://relaytx.com/    \n\n        \n                        \n        \n                        \n                        \n                        \n                    \n\n        \n        The information shared during this webinar is provided for educational and informational purposes only. It is not intended to replace professional medical advice\, diagnosis\, or treatment. Every person’s experience with breast cancer is unique. We encourage you to consult your physician or qualified healthcare provider with questions about your specific condition\, treatment options\, or medical decisions.\nTigerlily Foundation is committed to empowering patients with knowledge so they can engage in informed conversations with their healthcare teams.
URL:https://tigerlilyfoundation.org/event/your-choice-community-dialogues-about-clinical-trials-dc-2/
LOCATION:Whitman-Walker – Max Robinson Center\, 1201 Sycamore Drive Southeast\, Washington\, D\, 20032\, United States
CATEGORIES:CHOICE
ATTACH;FMTTYPE=image/jpeg:https://tigerlilyfoundation.org/wp-content/uploads/2025/07/2624413_BCFWxTLFChoiceEvent_01Ver2_1200x630_070325.jpg
END:VEVENT
END:VCALENDAR